We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$170M
AUM Growth
-$46.4M
Cap. Flow
-$59.1M
Cap. Flow %
-34.76%
Top 10 Hldgs %
31.2%
Holding
186
New
36
Increased
34
Reduced
25
Closed
39

Top Buys

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$15.6M
2
MTRN icon
Materion
MTRN
+$2.82M
3
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.75M
4
AIRG icon
Airgain
AIRG
+$1.62M
5
ICAD
iCAD Inc
ICAD
+$1.45M

Top Sells

Rank Stock Value
1
PDFS icon
PDF Solutions
PDFS
+$6.02M
2
SIMO icon
Silicon Motion
SIMO
+$5.45M
3
PLAB icon
Photronics
PLAB
+$5.19M
4
ADTN icon
Adtran
ADTN
+$4.61M
5
ESS icon
Essex Property Trust
ESS
+$3.54M

Sector Composition

Rank Sector Weight
1 Technology 16.75%
2 Healthcare 12.79%
3 Consumer Discretionary 5.93%
4 Financials 5.74%
5 Real Estate 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCYX icon
26
SCYNEXIS
SCYX
$37.4M
$1.19M 0.7%
70,065
PXLW icon
27
Pixelworks
PXLW
$37.2M
$1.04M 0.61%
38,916
+20,417
+110% +$528K
TTGT icon
28
TechTarget
TTGT
$327M
$993K 0.58%
16,393
+1,362
+9% +$95K
RFIL icon
29
RF Industries
RFIL
$116M
$924K 0.54%
128,684
TELA icon
30
TELA Bio
TELA
$30.3M
$904K 0.53%
+113,012
New +$938K
BKTI icon
31
BK Technologies
BKTI
$295M
$864K 0.51%
69,087
MDNA
32
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$846K 0.5%
571,489
NTST
33
NETSTREIT Corp
NTST
$2.13B
$797K 0.47%
38,780
+3,500
+10% +$73.8K
ITI
34
DELISTED
Iteris, Inc.
ITI
$770K 0.45%
272,944
+109,039
+67% +$303K
BKNG icon
35
Booking.com
BKNG
$156B
$725K 0.43%
9,875
-3,400
-26% -$290K
ALLT icon
36
Allot
ALLT
$362M
$691K 0.41%
135,509
+33,134
+32% +$193K
ATEN icon
37
A10 Networks
ATEN
$2.07B
$680K 0.4%
49,402
-35,143
-42% -$509K
LPTH icon
38
Lightpath Technologies
LPTH
$590M
$678K 0.4%
509,425
ARDX icon
39
Ardelyx
ARDX
$1.24B
$649K 0.38%
931,949
+163,913
+21% +$121K
KRTX
40
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$640K 0.38%
+4,800
New +$552K
APEN
41
DELISTED
Apollo Endosurgery, Inc.
APEN
$631K 0.37%
+124,400
New +$588K
IPWR icon
42
Ideal Power
IPWR
$55M
$584K 0.34%
52,888
CNTX icon
43
Context Therapeutics
CNTX
$56.7M
$565K 0.33%
297,612
-20,117
-6% -$37.7K
VCNX
44
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$564K 0.33%
2,418
+2,100
+660% +$537K
EQR icon
45
Equity Residential
EQR
$25.8B
$505K 0.3%
+6,962
New +$552K
APPS icon
46
Digital Turbine
APPS
$982M
$493K 0.29%
26,172
+6,811
+35% +$185K
CTO
47
CTO Realty Growth
CTO
$839M
$461K 0.27%
64,776
+46,236
+249% +$971K
CGTX icon
48
Cognition Therapeutics
CGTX
$80.6M
$459K 0.27%
228,170
+52,804
+30% +$136K
DCBO
49
Docebo
DCBO
$559M
$456K 0.27%
16,412
+5,467
+50% +$207K
RNAZ icon
50
TransCode Therapeutics
RNAZ
$5.25M
0

Similar funds

Worth Venture Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Worth Venture Partners held 186 positions worth $170M, down 21% from $217M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Worth Venture Partners withdrew a net $59.1M in Q2 2022, closing 39 positions and reducing 25 holdings. Its most notable exit was PDF Solutions, an estimated $6.02M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Materion worth $2.65M.

  • Worth Venture Partners's largest Q2 2022 buy was Materion: 35,126 shares worth $2.65M.
  • Worth Venture Partners added most to Carvana in Q2 2022, an estimated $15.6M increase.
  • Worth Venture Partners's biggest Q2 2022 reduction was Silicon Motion, cutting an estimated $5.45M.
  • Worth Venture Partners fully exited PDF Solutions in Q2 2022, selling an estimated $6.02M.
  • Worth Venture Partners's ten largest holdings make up 31% of its $170M portfolio in Q2 2022.
  • Worth Venture Partners opened 36 new positions and closed 39 in Q2 2022.
  • Worth Venture Partners's portfolio value fell 21% quarter-over-quarter to $170M.

Based on Worth Venture Partners's 13F filing for Q2 2022, filed 15 Aug 2022.